drugset / Trial / NCT06786728

Decongestion Guided By VExUS Score Or Lung Ultrasound For Renal Recovery In Patients With Cardiorenal Syndrome Type -1

NCT06786728

Enrolling by invitation 146 enrolled Benha University
RandomizedParallel-groupOpen-labelTreatment

Summary

the goal of this observational study is to evaluate the role of VEXUS score and lung ultrasound to guide decongestive therapy in patients with cardiorenal syndrome type -1. the main question it aims to answer is: Can the VEXUS score and lung ultrasound guide the efffect of decongestive therapy on KFR and decongestion metrics in patients with CRS-1 compared to standard assesment ?

Timeline

Start
2024-08-10
Primary completion
2025-07
Completion
2025-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Furosemide Other / unclassified

Indications